Cited by 59Multiple Sclerosis Research StudiesGlaucoma and retinal disordersRetinal and Optic Conditions

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis

Open access

Abstract

BACKGROUND AND OBJECTIVES: The optic nerve has been recommended as an additional region for demonstrating dissemination in space (DIS) in diagnostic criteria for multiple sclerosis (MS). The aim of this study was to investigate whether adding the optic nerve region as determined by optical coherence tomography (OCT) as part of the DIS criteria improves the 2017 diagnostic criteria. METHODS: From a prospective observational study, we included patients with a first demyelinating event who had complete information to assess DIS and a spectral domain OCT scan obtained within 180 days. Modified DIS criteria (DIS + OCT) were constructed by adding the optic nerve to the current DIS regions based on validated thresholds for OCT intereye differences. Time to second clinical attack was the primary endpoint. RESULTS: We analyzed 267 patients with MS (mean age 31.3 years [SD 8.1], 69% female) during a median observation period of 59 months (range: 13-98). Adding the optic nerve as a fifth region improved the diagnostic performance by increasing accuracy (DIS + OCT 81.2% vs DIS 65.6%) and sensitivity (DIS + OCT 84.2% vs DIS 77.9%) without lowering specificity (DIS + OCT 52.2% vs DIS 52.2%). Fulfilling DIS + OCT criteria (≥2 of 5 DIS + OCT regions involved) indicated a similar risk of a second clinical attack (hazard ratio [HR] 3.6, CI 1.4-14.5) compared with a 2.5-fold increased risk when fulfilling DIS criteria (HR 2.5, CI 1.2-11.8). When the analysis was conducted according to topography of the first demyelinating event, DIS + OCT criteria performed similarly in both optic neuritis and nonoptic neuritis. DISCUSSION: Addition of the optic nerve, assessed by OCT, as a fifth region in the current DIS criteria improves diagnostic performance by increasing sensitivity without lowering specificity. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that adding the optic nerve as determined by OCT as a fifth DIS criterion to the 2017 McDonald criteria improves diagnostic accuracy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000207507

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 37

  1. 10.1002/ana.20703 · DOI · Paper page
  2. 10.1002/ana.22366 · DOI · Paper page
  3. 10.1016/s1474-4422(13)70259-x · DOI
  4. 10.1002/ana.24351 · DOI
  5. 10.1016/s1474-4422(17)30278-8 · DOI · Paper page
  6. 10.1093/brain/awz038 · DOI
  7. 10.1212/wnl.0000000000006207 · DOI
  8. 10.1016/s1474-4422(10)70168-x · DOI
  9. 10.1016/j.msard.2020.101988 · DOI
  10. 10.1212/WNL.0000000000009504 · DOI
  11. 10.1212/wnl.0000000000009832 · DOI
  12. 10.1212/wnl.0000000000009840 · DOI
  13. 10.1111/ene.13443 · DOI
  14. 10.1097/wno.0000000000000629 · DOI
  15. 10.1136/jnnp-2021-327468 · DOI
  16. 10.1016/j.msard.2020.102403 · DOI
  17. 10.2147/eb.s139417 · DOI
  18. 10.1016/s1474-4422(15)00393-2 · DOI · Paper page
  19. 10.1016/s1474-4422(17)30469-6 · DOI · Paper page
  20. 10.1212/wnl.0000000000011339 · DOI
  21. 10.1212/wnl.33.11.1444 · DOI · Paper page
  22. 10.1001/archopht.1985.01050120030015 · DOI
  23. 10.1177/1352458514538110 · DOI
  24. 10.1212/wnl.0000000000002774 · DOI
  25. 10.1002/ana.25462 · DOI · Paper page
  26. 10.1002/sim.5889 · DOI
  27. 10.1097/wno.0000000000000704 · DOI
  28. 10.1212/wnl.0000000000003144 · DOI · Paper page
  29. 10.1212/wnl.0000000000002975 · DOI · Paper page
  30. 10.1167/iovs.03-1213 · DOI
  31. 10.1016/j.jocn.2018.11.011 · DOI
  32. 10.1007/s00417-013-2337-0 · DOI
  33. 10.1212/wnl.0000000000006873 · DOI
  34. 10.1007/s13311-016-0479-6 · DOI
  35. 10.1093/brain/awv105 · DOI · Paper page
  36. 10.1093/brain/awm329 · DOI · Paper page
  37. 10.1177/1352458517721054 · DOI

Cited by

Sorted by citations

See all 59

Metadata

Authors
Bsteh, G., Hegen, H., Altmann, P., Auer, M., Berek, K., Di Pauli, F., Kornek, B., Krajnc, N., Leutmezer, F., Macher, S., Rommer, P. S., Zebenholzer, K., Zulehner, G., Zrzavy, T., Deisenhammer, F., Pemp, B., Berger, T., & for VMSD (Vienna Multiple Sclerosis Database) Group
Affiliations
  • Medical University of Vienna (AT)
  • From the Department of Neurology (G.B., P.A., B.K., N.K., F.L., S.M., P.S.R., K.Z., G.Z., T.Z., T.B.), Medical University of Vienna; Comprehensive Center for Clinical Neurosciences and Mental Health (G.B., P.A., B.K., N.K., F.L., S.M., P.S.R., K.Z., G.Z., T.Z., T.B.), Medical University of Vienna; Department of Neurology (H.H., M.A., K.B., F.D.P., F.D.), Medical University of Innsbruck; and Department of Ophthalmology (B.P.), Medical University of Vienna, Austria.
Corresponding author
Bsteh, Gabriel
Venue
Neurology
Published
2023-08-22
Volume
101
Issue
8
Pages
e784-e793
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W4382933499
Cited by
59
References
3
Citations by year
2026: 16 · 2025: 24 · 2024: 15 · 2023: 4
FWCI
11.74
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Sanofi
  • Biogen
  • Teva Pharmaceutical Industries
  • Alexion Pharmaceuticals
  • Celgene
  • European Committee for Treatment and Research in Multiple Sclerosis
  • Amicus Therapeutics
  • Santen
  • MedDay Pharmaceuticals
  • Allergan
  • Sanofi Genzyme
  • Cilag
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal and Optic Conditions
Keywords
multiple sclerosis, dissemination in space, optic nerve, optical coherence tomography, 2017 McDonald criteria, diagnostic accuracy, first demyelinating event, optic neuritis, sensitivity and specificity
MeSH terms
Adult, Female, Humans, Male, Multiple Sclerosis, Optic Nerve, Optic Neuritis, Prospective Studies, Tomography, Optical Coherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review